Photo of Stanley Jutkowitz

Stanley Jutkowitz is the editor for The Blunt Truth®, as well as a Corporate senior counsel in the Washington, DC office and chair of Seyfarth's Cannabis Law practice group. Stan was named a 2020 “Trailblazer” for Cannabis Law by the National Law Journal.

Cannabis would move to Schedule III from Schedule I under this reclassification.

In a move long awaited by the cannabis industry, the Drug Enforcement Administration (DEA) has decided to re-schedule cannabis. Currently classified under Schedule I, along with heroin, cannabis would now move to Schedule III, along with ketamine and anabolic steroids.

This would not legalize cannabis for adult-use; rules


As many states continue to ease regulations and the Food and Drug Administration considers moving cannabis to Schedule III, commercial real estate is increasingly buzzed with interest in properties for use by cannabis businesses, from agricultural land and warehouses to retail spaces. Despite this seemingly abundant opportunity, investors currently find themselves navigating the still murky waters of federal illegality.

The Blunt Truth’s Stan Jutkowitz joins James O’Brien and Eric Greenberg on The Property LineTM Podcast to discuss the cannabis industry landscape, hurdles faced when securing and investing in suitable real estate, and risks and liabilities for owners leasing to cannabis businesses.Continue Reading Highs and Lows of Cannabis CRE

College athletes around the country may soon be in for an unexpected change in drug testing requirements. The NCAA Committee on Competitive Safeguards and Medical Aspects of Sports (CSMAS) recently showed support for removing cannabis from the organization’s banned drug list and testing protocols. The committee will discuss the decision with its members throughout the summer and final action will be decided on in the fall. Action items the committee will focus on include considering whether NCAA drug testing should only be limited to performance-enhancing substances, and seeking approval from the NCAA Board of Governors to stop testing for cannabis at championship events while the ultimate legislative decision is pending. To finalize the decision of cannabis being removed from the NCAA’s list of banned drugs, all three of its divisional governance bodies have to introduce and adopt legislation.Continue Reading Puff-Puff-Pass the Ball? NCAA Ponders a Different Kind of High Standard for Drug Testing Athletes

Governor Kathy Hochul’s determined efforts to combat illegal cannabis operations in New York have gained even more momentum with a new multi-agency initiative authorized as part of the 2024 Budget. The State aims to curtail the sale of untested cannabis from unlicensed shops through comprehensive inspections and enforcement actions. Additionally, New York City Council’s unanimous passing of a new bill now prohibits landlords from knowingly leasing commercial spaces to stores selling unlicensed marijuana or tobacco products, further strengthening the crackdown on illicit cannabis sales.Continue Reading Second-Hand Smoke: New York’s Crackdown on Illegal Cannabis Sales Extends to Landlords

The Blunt Truth® has long covered the intersection of alcohol and cannabis. For example, just last month we explored the potential for regulatory confusion that might ensue if states begin allowing the sale of cannabis in liquor stores. We also commented on the potential casual use of cannabis in the workplace, with some co-working environments expanding access to alcohol and more.

As more and more states legalize cannabis, regulators seem to be turning to a friendly source for guidance––the alcoholic beverage industry. While some remain cautiously optimistic as to the impact that regulation of cannabis might have on the alcoholic beverage industry, many industry leaders welcome the marriage of pot and potent potables,  and are even exploring a whole new marketplace of cannabis-infused products, such as weed wine, beer, and spirits. Nevertheless, the overarching concern that the alcoholic beverage industry has from entering into the cannabis industry is that cannabis remains illegal at the federal level.Continue Reading Cannabis Receives a Welcome Push from The Alcoholic Beverage Industry, Leaving Regulators Buzzing

The SAFE Banking Act is no longer in the National Defense Authorization Act and therefore will not pass in this Congress. For weeks, both industry sources and Congressional sources have been predicting that SAFE would pass in the lame duck session.  As late as this past Friday, we heard from two different sources who attended a meeting with Democratic Senate

Continue Reading SAFE Banking Is Not Safe

It has already been a busy year for marijuana law! Catch up on key legislative, regulatory, and legal developments affecting the manufacture, distribution, sale, and use of marijuana occurring in 2022, including key decisions and regulatory material.

Date Development
May 26, 2022 Governor Kevin Stitt signed legislation enacting a moratorium on some new medical marijuana licenses, effective on August 1,

Continue Reading In Case You Missed It: Key Marijuana Law Developments in 2022

During the last two weeks, the U.S. House of Representatives passed two bills aimed at reforming marijuana laws, the Marijuana Opportunity, Reinvestment and Expungement Act (MORE Act) and the Medical Marijuana Research Act (MMJ Research Act).  Since neither bill will be considered by the Senate in the present session of Congress, they will have to be reintroduced and pass both
Continue Reading The House Passes the MORE Act and the Medical Marijuana Research Act. Will It Matter?

THC, CBD, CBN…the Cannabis industry is quite familiar with acronyms. But it’s another nasty little four letters, TCPA, that are – or should be – on the top of mind for every dispensary, delivery service, CRM platform, and private equity holding company. This as the US Supreme Court decides what the byzantine 30-year-old law will look like following a landmark decision expected by the end of June or July.
Continue Reading Mass Texts: How the Cannabis Industry Must Deal with the Surge of TCPA Class Actions During Covid-19